Difference between revisions of "Team:British Columbia/Parts"

Line 9: Line 9:
  
 
   <style>
 
   <style>
 +
 +
  h2{
 +
    font: Neoteric;
 +
    color: #4A857E;
 +
    font-size: 26pt;
 +
    -webkit-text-stroke: 1.7px;
 +
    font-weight:lighter;
 +
    margin-left: 60px;
 +
    margin-right: 60px;
 +
letter-spacing: 2px;
 +
  }
  
 
p {
 
p {
Line 15: Line 26:
 
     font-size: 15pt !important;
 
     font-size: 15pt !important;
 
letter-spacing: -1px;
 
letter-spacing: -1px;
 +
    margin-left: 60px;
 +
    margin-right: 60px;
 
     line-height: 25px !important;
 
     line-height: 25px !important;
−
margin-left: 100px;
 
 
   }
 
   }
−
 
−
 
−
h4{
 
−
    font-family: Josefin Sans;
 
−
    color: #4a857e;
 
−
    font-size: 20pt;
 
−
  letter-spacing: -1px;
 
−
  margin-left: 150px;
 
−
    -webkit-text-stroke: 1px;
 
−
  }
 
−
 
 
.row {
 
.row {
 
     margin-bottom: 10px;
 
     margin-bottom: 10px;
Line 54: Line 55:
 
       <div class="container">
 
       <div class="container">
 
       <div>
 
       <div>
 +
    <img src="https://static.igem.org/mediawiki/2018/2/2b/T--British_Columbia--parts-hdg.png"  style="height:70px; margin-top:30px;margin-left:50px;">
 +
      </div>
 +
 
 +
    <div id="in-content">
 +
      <div class="container">
  
 +
          <div class = "row">
 +
          <h2>BBa_K2700000</h2>
 +
        </div>
 +
<div class = "row">
 +
      <p>This is a regulatory part that converts our previously synthesized Naringenin into our final product, Kaempferol. </p>
 +
        </div>
  
 +
  <div class = "row">
 +
          <h2>BBa_K2700001</h2>
 +
        </div>
 +
<div class = "row">
 +
          <p>This is our pt181-antisense-RNA transcript that will block both transcription and translation at the pt181 promoter (Part:BBa_K2700002) site. Once pt181-antisense is expressed, it will bind to the promoter region and cause a physical fold to occur. This fold is a stem-like structure that will block the RBS as well as act as a terminator to prevent further transcription to occur. </p>
 +
</div>
  
−
    <img src="https://static.igem.org/mediawiki/2018/2/2b/T--British_Columbia--parts-hdg.png" style="height:70px; margin-top:30px;margin-left:50px;">
+
<div class = "row">
−
      </div>
+
          <h2>BBa_K2700002</h2>
 +
        </div>
 +
  <div class = "row">
 +
          <p>This is our pt181-promoter region for our biosensor.</p>
 +
</div>
 +
</body>
 +
</html>

Revision as of 01:00, 17 October 2018

BBa_K2700000

This is a regulatory part that converts our previously synthesized Naringenin into our final product, Kaempferol.

BBa_K2700001

This is our pt181-antisense-RNA transcript that will block both transcription and translation at the pt181 promoter (Part:BBa_K2700002) site. Once pt181-antisense is expressed, it will bind to the promoter region and cause a physical fold to occur. This fold is a stem-like structure that will block the RBS as well as act as a terminator to prevent further transcription to occur.

BBa_K2700002

This is our pt181-promoter region for our biosensor.